Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • CCC Cancer Update
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Frontiers in neurology. 2020 Jul 7. doi: 10.3389/fneur.2020.00603. pmc: PMC7358578
    Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
    de Vries PJ1,  Belousova E2,  Benedik MP3,  Carter T4,  Cottin V5,  Curatolo P6,  Dahlin M7,  D'Amato L8,  Beaure d'Augères G9,  Ferreira JC10,  Feucht M11,  Fladrowski C12,  Hertzberg C13,  Jozwiak S14,  Lawson JA15,  Macaya A16,  Marques R17,  Nabbout R18,  O'Callaghan F19,  Qin J20,  Sander V21,  Sauter M22,  Shah S23,  Takahashi Y24,  Touraine R25,  Youroukos S26,  Zonnenberg B27,  Kingswood JC28,  Jansen AC29
    Author information
    1Division of Child and Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa.
    2Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia.
    3SPS Pediatrična Klinika, Ljubljana, Slovenia.
    4TSA Tuberous Sclerosis Association, Nottingham, United Kingdom.
    5Hôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France.
    6Tor Vergata University Hospital, Rome, Italy.
    7Astrid Lindgren Childrens Hospital, Stockholm, Sweden.
    8Novartis Farma S.p.A., Origgio, Italy.
    9Association Sclérose Tubéreuse de Bourneville, Gradignan, France.
    10Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
    11Universitätsklinik für Kinder-und Jugendheilkunde, Affiliated Partner of the ERN EpiCARE, Vienna, Austria.
    12Associazione Sclerosi Tuberosa ONLUS, Milan, Italy.
    13Vivantes-Klinikum Neukölln, Berlin, Germany.
    14Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland.
    15The Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children's Hospital, Randwick, NSW, Australia.
    16Hospital Universitari Vall d'Hebron, Barcelona, Spain.
    17Novartis Farma S.p.A., Origgio, Italy.
    18Department of Pediatric Neurology, Necker Enfants Malades Hospital, Paris Descartes University, Paris, France.
    19Clinical Neurosciences Section, Institute of Child Health, University College London, London, United Kingdom.
    20Department of Pediatrics, Peking University People's Hospital (PKUPH), Beijing, China.
    21Tallinn Children Hospital, Tallinn, Estonia.
    22Klinikverbund Kempten-Oberallgäu gGmbH, Kempten, Germany.
    23Novartis Healthcare Pvt. Ltd., Hyderabad, India.
    24National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, Shizuoka, Japan.
    25Department of Genetics, CHU-Hôpital Nord, Saint-Étienne, France.
    26St. Sophia Children's Hospital, Athens, Greece.
    27University Medical Center, Utrecht, Netherlands.
    28Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre, St Georges University of London, London, United Kingdom.
    29Pediatric Neurology Unit, Department of Pediatrics, UZ Brussel VUB, Brussels, Belgium.
    Abstract

    Knowledge is increasing about TSC-Associated Neuropsychiatric Disorders (TAND), but little is known about the potentially confounding effects of intellectual ability (IA) on the rates of TAND across age, sex, and genotype. We evaluated TAND in (a) children vs. adults, (b) males vs. females, and (c) vs. mutations, after stratification for levels of IA, in a large, international cohort. Individuals of any age with a documented visit for TSC in the 12 months prior to enrolment were included. Frequency and percentages of baseline TAND manifestations were presented by categories of IA (no intellectual disability [ID, intelligence quotient (IQ)>70]; mild ID [IQ 50-70]; moderate-to-profound ID [IQ<50]). Chi-square tests were used to test associations between ID and TAND manifestations. The association between TAND and age (children vs. adults), sex (male vs. female), and genotype ( vs. ) stratified by IA levels were examined using the Cochran-Mantel-Haenszel tests. Eight hundred and ninety four of the 2,211 participants had formal IQ assessments. There was a significant association ( < 0.05) between levels of IA and the majority of TAND manifestations, except impulsivity ( = 0.12), overactivity ( = 0.26), mood swings ( = 0.08), hallucinations ( = 0.20), psychosis ( = 0.06), depressive disorder ( = 0.23), and anxiety disorder ( = 0.65). Once controlled for IA, children had higher rates of overactivity, but most behavioral difficulties were higher in adults. At the psychiatric level, attention deficit hyperactivity disorder (ADHD) was seen at higher rates in children while anxiety and depressive disorders were observed at higher rates in adults. Compared to females, males showed significantly higher rates of impulsivity and overactivity, as well as autism spectrum disorder (ASD) and ADHD. No significant age or sex differences were observed for academic difficulties or neuropsychological deficits. After controlling for IA no genotype-TAND associations were observed, except for higher rates of self-injury in individuals with mutations. Findings suggest IA as risk marker for most TAND manifestations. We provide the first evidence of male preponderance of ASD and ADHD in individuals with TSC. The study also confirms the association between and IA but, once controlling for IA, disproves the previously reported association with ASD and with most other TAND manifestations.


    Copyright © 2020 de Vries, Belousova, Benedik, Carter, Cottin, Curatolo, Dahlin, D'Amato, Beaure d'Augères, Ferreira, Feucht, Fladrowski, Hertzberg, Jozwiak, Lawson, Macaya, Marques, Nabbout, O'Callaghan, Qin, Sander, Sauter, Shah, Takahashi, Touraine, Youroukos, Zonnenberg, Kingswood and Jansen.

    KEYWORDS: TAND profile, TOSCA, TSC-associated neuropsychiatric disorders, intelligence quotient, tuberous sclerosis complex

    Publikations ID: 32733359
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt